Amlodidine + aliskiren
Prescrire International 21(129): 180
2012
ISSN/ISBN: 1167-7422 PMID: 22852284 Document Number: 658946
Document emailed within 1 workday
Related Documents
Allikmets, K. 2002: Aliskiren (Speedel) Current Opinion in Investigational Drugs 3(10): 1479-1482Westermann, D.; Savvatis, K.; Schultheiss, H.P.; Tschöpe, C. 2009: Rational of the use of aliskiren in hypertension and beyond Minerva Cardioangiologica 57(6): 761-772
Lindner, T. 2008: Aliskiren combined with losartan in diabetes and nephropathy New England Journal of Medicine 359(10): 1068-1069; Author Reply 1069-1070
2008: Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy Prescrire International 17(94): 47-50
Horký, K. 2010: Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases Vnitrni Lekarstvi 56(2): 120-126
Dieterle, W.; Corynen, S.; Vaidyanathan, S.; Mann, J. 2005: Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine International Journal of Clinical Pharmacology and Therapeutics 43(11): 527-535
Mazza, A.; Montemurro, D.; Zuin, M.; Schiavon, L.; Zorzan, S.; Chondrogiannis, S.; Ferretti, A.; Ramazzina, E.; Rubello, D. 2013: Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects Minerva Cardioangiologica 2013
Slabý, A.; Zák, A. 2010: Renin, prorenin, and the direct renin inhibitor aliskiren Casopis Lekaru Ceskych 149(2): 55-60